The global nasal corticosteroids market is experiencing consistent growth, driven by the increasing prevalence of respiratory conditions such as allergic rhinitis, sinusitis, and nasal inflammation. These medications are widely recognized as a first-line therapy due to their effectiveness in reducing inflammation and improving breathing. Growing environmental pollution, rising pollen levels,...